Drug Trial Radar · NCT03625739
Population Pharmacokinetics of Anti-tuberculosis Drugs in Children With Tuberculosis
Last checked: Nov 19, 2026Latest source record: Aug 15, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
800
Planned (sponsor's estimate)
Start
Jul 1, 2018
Primary completion
Oct 1, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Beijing Children's HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Shandong University; Hopital Universitaire Robert-Debre; Rennes University Hospital
- First posted
- Aug 10, 2018
Design
- Study type
- Observational
- Who can join
- All sexes, from 1 day, up to 18 years
Summary
As written by the sponsor on the registry.
This study is based on the hypothesis that the pharmacokinetics of anti-tuberculosis drugs in TB children are different from adults. The investigators aim to study the population pharmacokinetics of children receiving the anti-tuberculsis drugs for treatment of TB. In this study, the investigators will detect drug concentration in plasma by using residual blood samples of blood gas analysis and other clinical tests and employ computers for constructing population pharmacokinetic models. In addition, the investigators also want to correlate use of anti-tuberculsis drugs with treatment effectiveness and incidence of adverse effects in children. This novel knowledge will allow better and more rational approaches to the treatment of TB in children. It will also set the foundation for further studies to improve anti-tuberculosis drug therapies for children.
Conditions
- Tuberculosis
Interventions
anti-tuberculosis drugDrug
The intervention drugs are prescribed by treating caregiver
Primary outcomes
What the sponsor says the trial is designed to measure.
- maximum concentration (Cmax)Time frame: up to 4 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Beijing Children's Hospital of Capital Medical University
Beijing, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.